Achieve, Disc, Revolution among winners of initial FDA national priority vouchers
Source: SeekingAlpha
2025-10-17 07:12:04 ET
More on Regeneron, Achieve Life Sciences, etc.
- Regeneron: Growth Catalysts Incoming
- Achieve Life Sciences: Promising Pipeline But High Risks Makes Me Hold For Now
- Regeneron: Strong R&D Pipeline Drives Growth Outlook
- Regeneron gets FDA nod for Libtayo for squamous cell cancer
- Regeneron says $83M acquired IPR&D charge to negatively hit Q3 income
Read the full article on Seeking Alpha
For further details see:
Achieve, Disc, Revolution among winners of initial FDA national priority vouchers
Disc Medicine Inc.
NASDAQ: IRON
IRON Trading
-2.4% G/L:
$59.34 Last:
105,695 Volume:
$60.54 Open:
IRON Latest News
March 14, 2026 05:39:00 pm
IRON Investors Have Opportunity to Join Disc Medicine, Inc. Fraud Investigation with the Schall Law Firm
March 04, 2026 01:26:00 pm
Securities Investigation: Levi & Korsinsky Investigates Disc Medicine, Inc. (IRON) on Behalf of Investors
February 26, 2026 08:30:00 am
Disc Medicine Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
IRON Stock Data
$2,821,824,610
32,299,039
0.06%
62
N/A
Biotechnology & Life Sciences
Healthcare
US
Watertown
